Pacific Biosciences of California Inc (PACB)
2.135
+0.23
(+12.07%)
USD |
NASDAQ |
Jul 26, 16:00
2.12
-0.02
(-0.70%)
After-Hours: 20:00
Pacific Biosciences of California Price to Book Value: 0.8959 for July 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| July 25, 2024 | 0.7994 |
| July 24, 2024 | 0.7889 |
| July 23, 2024 | 0.7763 |
| July 22, 2024 | 0.7554 |
| July 19, 2024 | 0.6966 |
| July 18, 2024 | 0.7281 |
| July 17, 2024 | 0.8603 |
| July 16, 2024 | 0.9127 |
| July 15, 2024 | 0.6798 |
| July 12, 2024 | 0.705 |
| July 11, 2024 | 0.6295 |
| July 10, 2024 | 0.5455 |
| July 09, 2024 | 0.5497 |
| July 08, 2024 | 0.5623 |
| July 05, 2024 | 0.5497 |
| July 03, 2024 | 0.5455 |
| July 02, 2024 | 0.5371 |
| July 01, 2024 | 0.5036 |
| June 28, 2024 | 0.5749 |
| June 27, 2024 | 0.5707 |
| June 26, 2024 | 0.5686 |
| June 25, 2024 | 0.5875 |
| June 24, 2024 | 0.6085 |
| June 21, 2024 | 0.6169 |
| June 20, 2024 | 0.6588 |
| Date | Value |
|---|---|
| June 18, 2024 | 0.6903 |
| June 17, 2024 | 0.7008 |
| June 14, 2024 | 0.7386 |
| June 13, 2024 | 0.7763 |
| June 12, 2024 | 0.8309 |
| June 11, 2024 | 0.7638 |
| June 10, 2024 | 0.7931 |
| June 07, 2024 | 0.8435 |
| June 06, 2024 | 0.8603 |
| June 05, 2024 | 0.8561 |
| June 04, 2024 | 0.7554 |
| June 03, 2024 | 0.7847 |
| May 31, 2024 | 0.7512 |
| May 30, 2024 | 0.8141 |
| May 29, 2024 | 0.7638 |
| May 28, 2024 | 0.7868 |
| May 24, 2024 | 0.7847 |
| May 23, 2024 | 0.8141 |
| May 22, 2024 | 0.7763 |
| May 21, 2024 | 0.7679 |
| May 20, 2024 | 0.8057 |
| May 17, 2024 | 0.8477 |
| May 16, 2024 | 0.919 |
| May 15, 2024 | 0.9001 |
| May 14, 2024 | 0.9358 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5036
Minimum
Jul 01 2024
41.85
Maximum
Sep 29 2020
9.517
Average
5.150
Median
Price to Book Value Benchmarks
| Boston Scientific Corp | 5.527 |
| Align Technology Inc | 4.416 |
| Hologic Inc | 3.787 |
| Perspective Therapeutics Inc | 4.020 |
| Electromed Inc | 3.027 |
Price to Book Value Related Metrics
| PS Ratio | 2.775 |
| Price | 2.135 |
| Earnings Yield | -53.40% |
| Market Cap | 581.48M |